| Target Professions: | DO, MD, Nurse Practitioner, Physician Associate/Assistant |
| Target Specialties: | Pediatrics |
| Credits Available: | 5.00 AMA PRA Category 1 Credit™, ABIM MOC |
The Type 2 inflammatory response plays a key role in several conditions, including atopic dermatitis, eosinophilic esophagitis, and asthma. While these diseases may present differently, they share a common underlying pathway, creating opportunities for more targeted and effective treatments. Pediatricians are well versed in managing these conditions, and recognizing their interconnections can help optimize patient care.
Exciting advancements in treatment, including biologics and other innovative therapies, offer new hope for patients with more severe forms of Type 2 inflammatory diseases. While these treatments are typically initiated by subspecialists, pediatricians play a vital role in identifying patients who may benefit from these options and guiding them through the referral process.
This program will provide valuable insights into recognizing comorbidities, making informed treatment decisions, and ensuring timely referrals so that patients receive therapies that address the root cause of their disease, not just the symptoms.
Please answer the following questions to assess your understanding of managing patients with type 2 inflammatory diseases.
This module describes the alterations in the type 2 inflammatory pathway that lead to different diseases.
Targeted biologic therapies are an important treatment for patients with type 2 inflammatory diseases. Pediatricians need to know which patients are candidates for these therapies and how to refer them to subspecialists for assessment and treatment.
Different endotypes of atopic dermatitis are less prone to responding to traditional therapies. These patients are excellent candidates for newer, targeted therapies. It is important that they are diagnosed accurately in order to be referred for treatment.
This activity features a girl with AD whose parents feel that she is still having a moderate amount of symptoms despite different interventions.
This discussion explores the immunologic mechanisms behind pediatric atopic dermatitis, its clinical presentation, and emerging treatment options to enhance understanding and improve patient care.
In this module we learn about the importance of specific asthma endotypes.
This activity features a boy with asthma whose symptoms are not completely controlled despite several interventions.
This session examines the role of inflammation in pediatric asthma, key clinical features, and advancements in treatment strategies. Engage in discussion to improve disease management and outcomes. The group will also discuss pediatric-specific action plans for managing Type II inflammation.
This module introduces us to eosinophilic esophagitis, which is often misdiagnosed in early childhood.
This activity features an infant with feeding difficulties whose symptoms are not improving despite several interventions.
Please answer the following questions to assess your gained understanding of managing patients with type 2 inflammatory diseases.
In light of the information reviewed and discussed during this program, please share an action plan that you will implement to improve the diagnosis and management for your patients with type 2 inflammatory diseases.
This discussion will explore the pathophysiology, diagnosis, and treatment of pediatric eosinophilic esophagitis, with an emphasis on best practices for optimizing patient care.
